Industry News

Jun 16, 2009
By Pharmaceutical Technology Editors
Following changes to European legislation, the European Medicines Agency (EMEA) will make public some of the information in EudraCT — a database that contains information on clinical trials in Europe.
Jun 12, 2009
By Pharmaceutical Technology Editors
A new Faculty of Translational Medicine has been established in London (UK) that will increase support for, and enhance collaboration among, researchers as they search for new treatments and diagnostic tests for a range of diseases and conditions.
Jun 12, 2009
By Pharmaceutical Technology Editors
The European Medicines Agency (EMEA) has agreed to an EU-wide recall of all the remaining batches of Merck Serono's Raptiva because of the risk of a serious brain infection. Following the recall, the medicine will no longer be available anywhere in the European Union.
Jun 12, 2009
By Pharmaceutical Technology Editors
"EU governments need to ensure fast generic medicines uptake as market access and low market volume in key EU countries is still a real problem and is having a major negative impact on patient access to more affordable treatments."
Jun 12, 2009
By Pharmaceutical Technology Editors
India-based Kemwell plans to build a new biopharmaceutical manufacturing plant in Bangalore (India) in a strategic collaboration with Boehringer Ingelheim (BI, Germany).
Jun 12, 2009
By Pharmaceutical Technology Editors
The outcome of a concept paper by the UK's Medicines and Healthcare products Regulatory Agency (MHRA), which sought the input of stakeholders on the review and consolidation of the UK medicines legislation, has been published.
Jun 12, 2009
By Pharmaceutical Technology Editors
The European Commission?s (EC) Directorate-General for Enterprise and Industry (EC–DG Enterprise) announced last week that it will not continue preparing a commission directive on good manufacturing practices (GMPs) for certain excipients.
Jun 11, 2009
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Patent infringement claims and a lack of clear global trade distribution routes may be unraveling the country's generic-drug export industry.
Jun 11, 2009
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Also, TorreyPines Therapeutics to liquidate assets and dissolve company; EU's competition services to examine Pfizer/Wyeth merger; Akorn appoints Raj Rai interim CEO; more...
Jun 05, 2009
By Pharmaceutical Technology Editors
The Chief Operating Officer (COO) of one of the world?s largest generics manufacturers has condemned the launch of authorized generics during 180-day exclusivity periods.
native1_300x100
lorem ipsum